BARDA Archives - Page 2 of 2 - Knowledge Ecology International

KEI request to BARDA concerning Moderna obligations to disclose federal funding in patent applications

Posted on September 2, 2020 by Claire Cassedy

On September 2, 2020, Knowledge Ecology International (KEI) sent a letter to the Biomedical Advanced Research and Development Authority (BARDA) regarding a potential failure by Moderna, Inc. to disclose federal funding in patents supported by BARDA. KEI requested information concerning… Continue Reading →

Moderna

KEI Reports and Posts 2020. October 8. KEI on Moderna’s Oct 8, 2020 Statement on Intellectual Property Matters during the COVID-19 Pandemic. https://www.keionline.org/34112 2020. September 18. DARPA letter to KEI confirming investigation of Moderna for failure to report government funding… Continue Reading →

BARDA Responds to KEI, Public Citizen Letter Asking BARDA to Enforce Moderna Contract

Posted on August 5, 2020 by Kathryn Ardizzone

(More on Moderna here: https://www.keionline.org/moderna) On August 5, 2020, BARDA Acting Director Gary Disbrow sent KEI and Public Citizen a letter (PDF copy) responding to KEI and Public Citizen’s joint letter outlining how Moderna failed to honor a term of… Continue Reading →

KEI receives seven new contracts for COVID 19 research from BARDA and DOD, including five using “Other Transactions Authority” that weaken or eliminate Bayh-Dole and FAR Safeguards

Posted on July 1, 2020 by James Love

KEI has a number of outstanding requests under the United States Freedom of Information Act (FOIA) for contracts related to biomedical innovations to control or treat the COVID-19 pandemic. On Thursday, June 25, and Friday, June 26, we received a… Continue Reading →

KEI response to four GAO questions on transparency of ownership and management of intellectual property HHS funds

Posted on June 24, 2020 by James Love

On June 3, 2020, the U.S. Government Accountability Office (GAO) sent KEI four questions about the transparency of the intellectual property HHS owns and how HHS manages those rights. On June 22, 2020, we sent this response. KEI response to… Continue Reading →

KEI Briefing Note 2020:3 Other Transaction Agreements: Government Contracts that May Eliminate Protections for the Public on Pricing, Access and Competition, Including in Connection with COVID-19

Other Transaction Agreements: Government Contracts that May Eliminate Protections for the Public on Pricing, Access and Competition, Including in Connection with COVID-19 KEI Briefing Note 2020:3 June 29, 2020 (revision of June 24 version) Kathryn Ardizzone James Love The most… Continue Reading →

KEI Research Note 2020:2 Role of Private Sector, Governments and Charities in Funding Research and Development Related to Tocilizumab

KEI Research Note 2020:2 Role of Private Sector, Governments and Charities in Funding Research and Development Related to Tocilizumab Luis Gil Abinader, May 28, 2020. From the Introduction: The funding of R&D for tocilizumab can be described as having three… Continue Reading →

KEI Letter to Speaker Pelosi Regarding Use of “Other Transaction Authority” (OTA) in Coronavirus Bill to Escape Bayh-Dole Public Interest Safeguards

Posted on March 23, 2020 by KEI Staff

For more on KEI’s work on COVID-19, see keionline.org/coronavirus. On March 23, 2020, Knowledge Ecology International (KEI) sent a letter to Speaker Nancy Pelosi regarding a provision in the current draft of the Senate version of the coronavirus funding bill… Continue Reading →

Categories